高强度他类药物对生物活性脂质的一年效应:来自JUPITER试验的发现
Rosangela Akemi Hoshi1,2,3, Mona Alotaibi4,5, Yanyan Liu2,3
1Division of Cardiovascular Medicine (R.A.H., P.M.R., H.L.-G., S.M.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
高强度的他类药物治疗显著改变生物活性脂质代谢,增加抗炎性脂质,减少促炎性脂质. 这些发现支持了除了降低胆固醇之外,他类药物的更广泛的心脏保护作用.
科学领域:
- 利皮多米克 (Lipidomics) 是一种消化剂.
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 类药物除了降低LDL胆固醇之外,还可以通过调节生物活性脂质 (BALs) 来提供好处.
- BALs对于信号和炎症至关重要,作为他类药物的性作用的代谢足迹.
- 了解他类药物调节的BAL可以阐明心脏保护机制.
研究的目的:
- 研究高强度他类药物治疗对血BALs的影响.
- 分析JUPITER试验的初级预防队列中BALs的变化.
- 为了确定受罗斯瓦斯塔丁治疗影响的特定BALs.
主要方法:
- 非目标质谱分析了血样本中的超过11000个脂质特征.
- 使用了来自JUPITER试验替代研究 (发现和验证) 的基线和1年样本.
- 对共变量进行调整的线性回归模型评估了罗斯瓦斯塔丁与安慰剂对BALs的影响.
主要成果:
- 达丁类药物治疗显著改变了610个脂质特征,其中26个是BALs.
- 276个特征,包括抗炎性BALs,由他类药物增加.
- 334个特征,包括促炎性BALs,通过他类药物减少,观察到一些与性别相关的差异.
结论:
- 达丁类药物治疗可提高抗炎,抗血小板和抗氧化剂BALs的调节.
- 达丁类药物治疗降低了促炎和血小板细胞聚合BALs的调节.
- 这些发现支持了除了减少LDL-C之外,他类药物的心血管益处.
更多相关视频
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Bioavailability: Overview
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
